CAS 1142363-52-7

Edicotinib

CAS : 1142363-52-7

Edicotinib (JNJ-527) is a blood-brain permeable, selective CSF-1R inhibitor, with lesser inhibitory effects on KIT and FLT3.Cost-effective and quality-assured.

Formule : C₂₇H₃₅N₅O₂

Degré de pureté : 98.58% - 99.72%

Couleur et forme : Solid

Masse moléculaire : 461.6

Ref: TM-T15199

5-Cyano-N-[2-(4,4-dimethylcyclohexen-1-yl)-6-(2,2,6,6-tetramethyloxan-4-yl)pyridin-3-yl]-1H-imidazole-2-carboxamide

CAS : 1142363-52-7

Formule : C₂₇H₃₅N₅O₂

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 461.5991

Ref: IN-DA01EO3B

Edicotinib

CAS : 1142363-52-7

Edicotinib

Degré de pureté : ≥98%

Masse moléculaire : 461.6g/mol

Ref: 54-BUP01982

JNJ-40346527

CAS : 1142363-52-7

JNJ-40346527

Degré de pureté : 99%

Masse moléculaire : 461.60g/mol

Ref: 54-BISN0042

JNJ-40346527

CAS : 1142363-52-7

JNJ-40346527 is an anti-inflammatory drug that belongs to the group of quinoline derivatives. It has been shown to have a tumor treatment effect in cancer cell lines and also inhibits the production of inflammatory cytokines such as tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6). JNJ-40346527 has been shown to be effective in treating bowel disease and rheumatoid arthritis. This molecule inhibits tumor growth by stimulating the release of colony-stimulating factor, which stimulates the proliferation of blood cells. The hydroxyl group on this molecule may contribute to its activity by interacting with DNA bases.

Formule : C₂₇H₃₅N₅O₂

Degré de pureté : Min. 95%

Masse moléculaire : 461.6 g/mol

Ref: 3D-SVB36352